This attenuation may occur because the impact of these variables is obscured by other more influential predictors (e.g., clinical prognostic stage and metastasis burden) or because they are associated with various confounding factors (e.g., Ki-67% correlates with tumor invasiveness, which is already reflected in clinical staging). Here, MKI67 is linked to neoplasm.